Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcatheter Aortic Valve Replacement | 56 | 2026 | 228 | 14.440 |
Why?
|
| Aortic Valve Stenosis | 49 | 2026 | 350 | 12.130 |
Why?
|
| Heart Valve Prosthesis | 47 | 2026 | 303 | 9.370 |
Why?
|
| Mitral Valve Insufficiency | 22 | 2025 | 178 | 6.270 |
Why?
|
| Heart Valve Prosthesis Implantation | 26 | 2026 | 425 | 5.800 |
Why?
|
| Aortic Valve | 46 | 2026 | 455 | 5.250 |
Why?
|
| Mitral Valve | 18 | 2025 | 247 | 2.350 |
Why?
|
| Prosthesis Design | 29 | 2026 | 643 | 1.790 |
Why?
|
| Cardiac Catheterization | 19 | 2026 | 630 | 1.720 |
Why?
|
| Treatment Outcome | 68 | 2026 | 12936 | 1.700 |
Why?
|
| Bioprosthesis | 5 | 2025 | 110 | 1.390 |
Why?
|
| Aortic Valve Insufficiency | 6 | 2026 | 149 | 1.310 |
Why?
|
| Bundle-Branch Block | 2 | 2020 | 41 | 1.190 |
Why?
|
| Tricuspid Valve Insufficiency | 3 | 2026 | 61 | 1.130 |
Why?
|
| Device Removal | 4 | 2026 | 225 | 1.110 |
Why?
|
| Aged, 80 and over | 33 | 2026 | 6797 | 1.070 |
Why?
|
| Prosthesis Failure | 8 | 2026 | 159 | 1.030 |
Why?
|
| Registries | 16 | 2026 | 1634 | 1.000 |
Why?
|
| Risk Factors | 42 | 2026 | 11074 | 0.950 |
Why?
|
| Percutaneous Coronary Intervention | 6 | 2025 | 299 | 0.850 |
Why?
|
| Predictive Value of Tests | 13 | 2026 | 2304 | 0.820 |
Why?
|
| Multidetector Computed Tomography | 7 | 2025 | 33 | 0.790 |
Why?
|
| Acute Coronary Syndrome | 5 | 2025 | 235 | 0.790 |
Why?
|
| Heart Valve Diseases | 5 | 2025 | 162 | 0.770 |
Why?
|
| Hemodynamics | 10 | 2026 | 810 | 0.760 |
Why?
|
| Reoperation | 12 | 2026 | 818 | 0.740 |
Why?
|
| Postoperative Complications | 14 | 2024 | 3147 | 0.730 |
Why?
|
| Humans | 89 | 2026 | 131163 | 0.720 |
Why?
|
| Aged | 36 | 2026 | 21025 | 0.690 |
Why?
|
| Ventricular Septum | 1 | 2020 | 16 | 0.620 |
Why?
|
| Retrospective Studies | 31 | 2026 | 17753 | 0.560 |
Why?
|
| Balloon Valvuloplasty | 3 | 2025 | 27 | 0.560 |
Why?
|
| Calcinosis | 3 | 2024 | 180 | 0.520 |
Why?
|
| Risk Assessment | 14 | 2026 | 3711 | 0.500 |
Why?
|
| Heart Ventricles | 1 | 2020 | 749 | 0.440 |
Why?
|
| Tricuspid Valve | 2 | 2026 | 58 | 0.410 |
Why?
|
| Catheters | 2 | 2024 | 78 | 0.390 |
Why?
|
| Time Factors | 16 | 2026 | 6196 | 0.390 |
Why?
|
| Radiography, Interventional | 2 | 2026 | 79 | 0.370 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 2 | 2024 | 20 | 0.360 |
Why?
|
| Echocardiography | 6 | 2025 | 1125 | 0.350 |
Why?
|
| Prosthesis-Related Infections | 2 | 2024 | 197 | 0.350 |
Why?
|
| Male | 34 | 2026 | 64957 | 0.340 |
Why?
|
| Treatment Failure | 4 | 2026 | 351 | 0.340 |
Why?
|
| Feasibility Studies | 5 | 2025 | 824 | 0.320 |
Why?
|
| Severity of Illness Index | 7 | 2024 | 3061 | 0.310 |
Why?
|
| Female | 32 | 2026 | 70963 | 0.310 |
Why?
|
| Recovery of Function | 7 | 2025 | 449 | 0.300 |
Why?
|
| Frailty | 2 | 2023 | 140 | 0.290 |
Why?
|
| Heart Failure | 4 | 2024 | 2332 | 0.290 |
Why?
|
| Workflow | 2 | 2026 | 144 | 0.270 |
Why?
|
| Middle Aged | 14 | 2025 | 28601 | 0.260 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2026 | 64 | 0.260 |
Why?
|
| Clinical Decision-Making | 4 | 2026 | 314 | 0.250 |
Why?
|
| Coronary Artery Disease | 2 | 2024 | 887 | 0.250 |
Why?
|
| Endocarditis | 2 | 2024 | 102 | 0.240 |
Why?
|
| Coronary Vessels | 2 | 2020 | 521 | 0.230 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2025 | 15 | 0.220 |
Why?
|
| Off-Label Use | 1 | 2024 | 29 | 0.210 |
Why?
|
| Atrial Pressure | 1 | 2024 | 6 | 0.210 |
Why?
|
| Mercury | 1 | 2024 | 31 | 0.200 |
Why?
|
| Atrial Function, Left | 1 | 2024 | 37 | 0.200 |
Why?
|
| Heart Valves | 1 | 2024 | 52 | 0.200 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2022 | 15 | 0.190 |
Why?
|
| Benzoates | 1 | 2022 | 24 | 0.190 |
Why?
|
| Propensity Score | 1 | 2024 | 271 | 0.190 |
Why?
|
| Pulmonary Veins | 1 | 2024 | 167 | 0.190 |
Why?
|
| Fluoroscopy | 4 | 2026 | 108 | 0.180 |
Why?
|
| Shock, Cardiogenic | 2 | 2021 | 176 | 0.180 |
Why?
|
| Follow-Up Studies | 5 | 2023 | 5196 | 0.180 |
Why?
|
| Computed Tomography Angiography | 2 | 2025 | 216 | 0.180 |
Why?
|
| Ultrasonography, Interventional | 1 | 2024 | 205 | 0.180 |
Why?
|
| Aortography | 2 | 2019 | 155 | 0.180 |
Why?
|
| Stents | 2 | 2025 | 799 | 0.180 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2022 | 43 | 0.170 |
Why?
|
| Databases, Factual | 2 | 2024 | 1240 | 0.170 |
Why?
|
| Intracranial Embolism | 1 | 2021 | 26 | 0.170 |
Why?
|
| Survival Rate | 5 | 2025 | 2114 | 0.160 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2019 | 7 | 0.150 |
Why?
|
| Patient Readmission | 2 | 2021 | 442 | 0.150 |
Why?
|
| Consensus | 3 | 2026 | 512 | 0.140 |
Why?
|
| Organ Size | 1 | 2020 | 407 | 0.140 |
Why?
|
| Health Resources | 1 | 2020 | 131 | 0.140 |
Why?
|
| Incidence | 2 | 2025 | 3360 | 0.140 |
Why?
|
| Outpatients | 1 | 2020 | 262 | 0.140 |
Why?
|
| Myocarditis | 1 | 2019 | 122 | 0.140 |
Why?
|
| Hemodynamic Monitoring | 1 | 2018 | 17 | 0.140 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2020 | 117 | 0.140 |
Why?
|
| Renal Dialysis | 1 | 2025 | 951 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 1 | 2025 | 934 | 0.130 |
Why?
|
| Coronary Angiography | 1 | 2019 | 450 | 0.120 |
Why?
|
| Benchmarking | 2 | 2026 | 137 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 570 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 558 | 0.110 |
Why?
|
| Pilot Projects | 4 | 2020 | 1445 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2023 | 1020 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 999 | 0.100 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2016 | 238 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2025 | 2065 | 0.090 |
Why?
|
| Hospital Mortality | 3 | 2021 | 1064 | 0.090 |
Why?
|
| North America | 2 | 2020 | 255 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1826 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1833 | 0.070 |
Why?
|
| United States | 5 | 2025 | 12072 | 0.070 |
Why?
|
| Age Factors | 2 | 2024 | 2825 | 0.070 |
Why?
|
| Anatomic Landmarks | 1 | 2026 | 20 | 0.060 |
Why?
|
| Texas | 2 | 2025 | 3686 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 1267 | 0.060 |
Why?
|
| Patient-Specific Modeling | 1 | 2025 | 12 | 0.060 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2024 | 15 | 0.050 |
Why?
|
| Systole | 1 | 2024 | 195 | 0.050 |
Why?
|
| Pulmonary Circulation | 1 | 2024 | 113 | 0.050 |
Why?
|
| Health Facilities | 1 | 2024 | 66 | 0.050 |
Why?
|
| Prognosis | 2 | 2024 | 4886 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2024 | 417 | 0.050 |
Why?
|
| Endocarditis, Bacterial | 1 | 2024 | 128 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2024 | 229 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2024 | 226 | 0.050 |
Why?
|
| Thinness | 1 | 2023 | 71 | 0.050 |
Why?
|
| Prasugrel Hydrochloride | 1 | 2022 | 23 | 0.040 |
Why?
|
| Dilatation | 1 | 2021 | 67 | 0.040 |
Why?
|
| Steroids | 1 | 2022 | 170 | 0.040 |
Why?
|
| Tachycardia, Ventricular | 1 | 2023 | 257 | 0.040 |
Why?
|
| Dobutamine | 1 | 2020 | 48 | 0.040 |
Why?
|
| Milrinone | 1 | 2020 | 30 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 434 | 0.040 |
Why?
|
| Radial Artery | 1 | 2020 | 32 | 0.040 |
Why?
|
| New York | 1 | 2020 | 69 | 0.040 |
Why?
|
| Health Status | 1 | 2022 | 378 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2023 | 541 | 0.040 |
Why?
|
| Overweight | 1 | 2023 | 387 | 0.040 |
Why?
|
| Femoral Artery | 1 | 2020 | 134 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 267 | 0.040 |
Why?
|
| Endocardium | 1 | 2019 | 45 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2023 | 482 | 0.040 |
Why?
|
| Europe | 1 | 2020 | 365 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 59 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2024 | 499 | 0.040 |
Why?
|
| Cardiotonic Agents | 1 | 2020 | 138 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 549 | 0.040 |
Why?
|
| Cardiac Catheters | 1 | 2018 | 11 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2021 | 396 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 387 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 2018 | 52 | 0.030 |
Why?
|
| Pneumonectomy | 1 | 2019 | 154 | 0.030 |
Why?
|
| Troponin T | 1 | 2019 | 259 | 0.030 |
Why?
|
| Prevalence | 1 | 2024 | 2701 | 0.030 |
Why?
|
| Medicare | 1 | 2021 | 442 | 0.030 |
Why?
|
| Adult | 3 | 2025 | 31282 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 246 | 0.030 |
Why?
|
| Aging | 1 | 2024 | 1242 | 0.030 |
Why?
|
| Young Adult | 2 | 2024 | 10103 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2023 | 1717 | 0.030 |
Why?
|
| Morocco | 1 | 2016 | 3 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1239 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 1 | 2016 | 36 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 110 | 0.030 |
Why?
|
| Heart | 1 | 2019 | 650 | 0.030 |
Why?
|
| Introns | 1 | 2016 | 278 | 0.030 |
Why?
|
| Myocardium | 1 | 2019 | 852 | 0.030 |
Why?
|
| Age of Onset | 1 | 2016 | 592 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2016 | 353 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2019 | 970 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 371 | 0.020 |
Why?
|
| Adolescent | 2 | 2024 | 20987 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 2596 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2016 | 430 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 760 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 1673 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2426 | 0.020 |
Why?
|
| Hospitalization | 1 | 2020 | 1950 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 5063 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 1545 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2904 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3359 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3763 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2833 | 0.020 |
Why?
|
| Infant | 1 | 2016 | 13352 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2016 | 15110 | 0.010 |
Why?
|
| Child | 1 | 2016 | 26341 | 0.010 |
Why?
|